Clinical Notes: Drug Chosen for Major AD Study

by MedPage Today • 2013/01/20 • 0 Comments

(MedPage Today) -- The investigational anti-amyloid drug solanezumab will be tested in a landmark Alzheimer's disease prevention trial. Also this week: "bait bottles" to catch drug thieves.

Full Story →

← CHMP Gives Thumbs Up on Jetrea, Thumbs Down on Raxone

Pharmacogenetics for Genes Associated with Age-related Macular Degeneration in the Comparison of AMD Treatments Trials (CATT) →

Post navigation